Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 4/20 | 0.70 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.61 |
| ▸ | JAK2 | O60674 | 1/20 | 0.56 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.56 |
| ▸ | MELK | Q14680 | 1/20 | 0.56 |
| ▸ | STK24 | Q9Y6E0 | 1/20 | 0.56 |
| ▸ | TYMS | P04818 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylamine SCHEMBL4294725 | 0.90 | PARP1 (0.58) | PARP1CHEK1JAK2RPS6KA3MELK | |
| SCHEMBL57212 | 0.83 | PARP1 (1.00) | PARP1CHEK1JAK2RPS6KA3MELK | |
| SCHEMBL29365341 | 0.83 | PARP1 (1.00) | PARP1CHEK1JAK2RPS6KA3MELK | |
| Hydrochloric Acid SCHEMBL2455495 | 0.81 | PARP1 (0.95) | PARP1CHEK1JAK2RPS6KA3MELK | |
| Benzene SCHEMBL670928 | 0.81 | PARP1 (0.95) | PARP1CHEK1JAK2RPS6KA3MELK | |
| SCHEMBL670718 | 0.81 | PARP1 (0.95) | PARP1CHEK1JAK2RPS6KA3MELK | |
| Hydrochloric Acid SCHEMBL7380702 | 0.81 | PARP1 (0.95) | PARP1CHEK1JAK2RPS6KA3MELK | |
| Hydrochloric Acid SCHEMBL30294983 | 0.81 | PARP1 (0.95) | PARP1CHEK1JAK2RPS6KA3MELK | |
| Potassium SCHEMBL3099047 | 0.81 | PARP1 (0.95) | PARP1CHEK1JAK2RPS6KA3MELK | |
| SCHEMBL27946369 | 0.81 | PARP1 (0.95) | PARP1CHEK1JAK2RPS6KA3MELK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113754866-B | Triphenylamine-carbazole-naphthalene benzimidazole terpolymer, preparation method and application thereof in electric storage device | 黑龙江大学 | 2023-06-23 | — | — | CN | claimed |
| CN-111944125-B | Terpolymer of triphenylamine donor group containing alkoxy, electric memory device and preparation thereof | 华南理工大学 | 2022-07-26 | — | — | CN | claimed |
| US-20090253895-A1 | Printable Materials | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2009-10-08 | — | — | US | claimed |
| JP-2009504872-A | — | — | 2009-02-05 | — | — | JP | claimed |
| EP-1922381-A1 | PRINTABLE MATERIALS | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION, LTD. (IL) | 2008-05-21 | — | — | EP | claimed |
| WO-2007020636-A1 | PRINTABLE MATERIALS | TECHNION RESEARCH AND DEVELOPMENT FOUNDATION LTD. (IL) | 2007-02-22 | — | — | WO | claimed |
| US-5874444-A | CONTROLLING CELL AGING | GERON CORPORATION (US) | 1999-02-23 | — | — | US | claimed |
| CN-119895590-A | Positive electrode and all-solid-state secondary battery including the same | 三星SDI株式会社 | 2025-04-25 | — | — | CN | disclosed |
| CN-119768931-A | Composite anode active material, anode and lithium battery using the same and preparation method thereof | 三星SDI株式会社 | 2025-04-04 | — | — | CN | disclosed |
| CN-115050921-B | Electrode, lithium battery including the same, and method of manufacturing the same | 三星SDI株式会社 | 2024-10-01 | — | — | CN | disclosed |
| CN-118712325-A | Dry electrode, method of manufacturing the same, and lithium battery including the same | 三星SDI株式会社 | 2024-09-27 | — | — | CN | disclosed |
| CN-118712326-A | Electrode structure and lithium battery including the same | 三星SDI株式会社 | 2024-09-27 | — | — | CN | disclosed |
| CN-118712506-A | Lithium battery including modified polyolefin binder | 三星SDI株式会社 | 2024-09-27 | — | — | CN | disclosed |
| WO-1999031063-A1 | NEW PIPERAZINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999031064-A1 | ARYL-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999031060-A2 | PIPERIDINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKINE CARBOXAMIDES AS CYTOSTATICS AND IMMUNESUPPRESSANTS | KLINGE PHARMA GMBH (DE) | 1999-06-24 | — | — | WO | disclosed |
| WO-1999011645-A1 | POLY(ADP-RIBOSE) POLYMERASE ('PARP') INHIBITORS, METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING NEURAL OR CARDIOVASCULAR TISSUE DAMAGE | GUILFORD PHARMACEUTICALS INC. (US) | 1999-03-11 | — | — | WO | disclosed |
| US-5874444-A | CONTROLLING CELL AGING | GERON CORPORATION (US) | 1999-02-23 | — | — | US | disclosed |
| US-5059607-A | Suppresses vomiting induced by anti-cancer agents | ONO-PHARMACEUTICAL CO., LTD. (JP) | 1991-10-22 | — | — | US | disclosed |
| EP-0405784-A1 | Novel benzisoquinoline derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1991-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090253895-A1 | Printable Materials | SLC11A2, CABLES1, ILK | PARP1 1330/4885CHEK1 4744/4885JAK2 2685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.